PT  - JOURNAL ARTICLE
AU  - Mor, Saban
AU  - Anna, Reznik
AU  - Tal, Shachar
AU  - Roten, Sivan-Hoffmann
TI  - Reduction in stroke patients’ referral to the ED in the COVID-19 era: A four-year comparative study
AID  - 10.1101/2020.05.30.20118125
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.30.20118125
4099  - http://medrxiv.org/content/early/2020/06/03/2020.05.30.20118125.short
4100  - http://medrxiv.org/content/early/2020/06/03/2020.05.30.20118125.full
AB  - Introduction Current reports indicate that the increased use of social distancing for preventive COID-19 distribution may have a negative effect on patients who suffering from acute medical conditions.Aim We examined the effect of social distancing on acute ischemic stroke (AIS) patients’ referral to the emergency department (ED)Method A retrospective archive study was conducted between January 2017 and April 2020 in a comprehensive stroke center. We compare the number of neurologic consultations, time from symptoms onset to ED arrival, patients diagnosis with AIS, number of patients receiving treatment (tPA, endovascular thrombectomy (EVT) or combine) and in-hospital death.Results The analysis included a total of 14,626 neurological consultations from the years 2017 to 2020. A significant decrease of 58.6% was noted during the months of January-April of the year 2020 compared to the parallel period of 2017. Percent of final AIS diagnosis for the year of 2020 represent 24.8% of suspected cases, with the highest diagnosis rate demarcated for the year of 2019 with 25.6% of confirmed patients. The most remarkable increase was noted in EVT performance through the examined years (2017, n=21; 2018, n=32; 2019, n=42; 2020, n=47).Conclusion COVID-19 pandemic resulted in routing constraints on health care system resources that were dedicated for treating COVID-19 patients.The healthcare system must develop and offer complementary solutions that will enable access to health services even during these difficult times.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review boards of the hospital (#3023-18-RMB).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors have no permission to share the data